Zibo Qixiang Tengda Chemical Co., Ltd
SZSE:002408.SZ
5.5 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 25,218.84 | 26,918.466 | 29,810.493 | 34,892.073 | 24,685.919 | 30,057.693 | 27,924.062 | 22,226.197 | 5,875.241 | 4,278.458 | 5,200.429 | 3,771.195 | 3,422.031 | 2,787.577 | 2,359.581 | 1,297.478 | 1,115.523 | 901.351 | 679.014 |
| Cost of Revenue
| 23,784.408 | 25,316.916 | 27,190.032 | 30,517.991 | 22,395.03 | 28,280.644 | 26,029.699 | 20,443.007 | 4,797.148 | 3,676.821 | 4,402.884 | 3,209.565 | 2,894.06 | 2,020.009 | 1,761.353 | 1,001.437 | 850.64 | 698.475 | 528.83 |
| Gross Profit
| 1,434.432 | 1,601.55 | 2,620.46 | 4,374.081 | 2,290.889 | 1,777.049 | 1,894.363 | 1,783.19 | 1,078.093 | 601.638 | 797.545 | 561.63 | 527.971 | 767.568 | 598.228 | 296.041 | 264.882 | 202.876 | 150.183 |
| Gross Profit Ratio
| 0.057 | 0.059 | 0.088 | 0.125 | 0.093 | 0.059 | 0.068 | 0.08 | 0.183 | 0.141 | 0.153 | 0.149 | 0.154 | 0.275 | 0.254 | 0.228 | 0.237 | 0.225 | 0.221 |
| Reseach & Development Expenses
| 675.474 | 655.42 | 705.6 | 578.563 | 271.206 | 316.138 | 307.289 | 281.856 | 180.126 | 131.203 | 151.843 | 98.548 | 75.541 | 61.154 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 81.946 | 91.499 | 93.475 | 177.101 | 159.057 | 149.902 | 91.875 | 45.024 | 61.2 | 23.15 | 30.12 | 16.294 | 6.135 | 14.213 | 21.855 | 17.382 | 22.252 | 19.793 | 13.282 |
| Selling & Marketing Expenses
| 63.888 | 75.184 | 114.556 | 128.069 | 95.536 | 190.422 | 164.198 | 163.564 | 110.796 | 85.89 | 68.341 | 49.324 | 45.22 | 37.208 | 38.466 | 28.381 | 24.008 | 14.877 | 12.218 |
| SG&A
| 145.834 | 470.214 | 208.03 | 305.17 | 254.593 | 340.324 | 256.073 | 208.588 | 171.996 | 109.04 | 98.461 | 65.618 | 51.355 | 51.42 | 60.321 | 45.763 | 46.26 | 34.67 | 25.5 |
| Other Expenses
| 575.034 | 737.435 | 448.557 | 297.382 | 236.098 | 219.631 | -0.392 | -0.862 | 24.257 | 18.166 | 25.391 | 120.164 | 12.576 | -2.372 | 3.768 | -1.769 | -0.6 | -0.789 | -0.117 |
| Operating Expenses
| 1,396.342 | 1,863.069 | 1,362.186 | 1,181.114 | 761.897 | 876.092 | 859.516 | 720.726 | 496.085 | 394.122 | 369.842 | 225.695 | 176.173 | 156.78 | 96.84 | 53.601 | 51.68 | 40.333 | 27.771 |
| Operating Income
| 38.09 | -261.519 | 1,165.097 | 2,851.374 | 1,246.617 | 705.953 | 977.133 | 991.971 | 557.896 | 200.291 | 348.197 | 316.285 | 375.671 | 632.087 | 504.366 | 231.066 | 192.605 | 163.499 | 120.739 |
| Operating Income Ratio
| 0.002 | -0.01 | 0.039 | 0.082 | 0.05 | 0.023 | 0.035 | 0.045 | 0.095 | 0.047 | 0.067 | 0.084 | 0.11 | 0.227 | 0.214 | 0.178 | 0.173 | 0.181 | 0.178 |
| Total Other Income Expenses Net
| 13.86 | -250.483 | -30.332 | -45.452 | -38.894 | 1.67 | -0.392 | -0.862 | 24.815 | 18.158 | 25.391 | 119.816 | 41.048 | -6.742 | 3.417 | -16.622 | -18.186 | -1.604 | -0.117 |
| Income Before Tax
| 51.95 | -512.002 | 717.956 | 2,805.922 | 1,207.723 | 707.623 | 976.741 | 991.109 | 582.152 | 218.449 | 373.587 | 436.101 | 388.246 | 625.345 | 507.864 | 229.297 | 192.005 | 161.895 | 120.623 |
| Income Before Tax Ratio
| 0.002 | -0.019 | 0.024 | 0.08 | 0.049 | 0.024 | 0.035 | 0.045 | 0.099 | 0.051 | 0.072 | 0.116 | 0.113 | 0.224 | 0.215 | 0.177 | 0.172 | 0.18 | 0.178 |
| Income Tax Expense
| 7.079 | -53.759 | 120.367 | 359.191 | 179.225 | 76.079 | 131.922 | 144.304 | 75.002 | 31.173 | 63.199 | 77.403 | 71.275 | 118.918 | 87.874 | 55.781 | 48.372 | 21.868 | 28.707 |
| Net Income
| 31.68 | -383.668 | 633.877 | 2,392.637 | 975.716 | 620.495 | 842.91 | 849.612 | 502.51 | 184.187 | 299.402 | 346.077 | 316.971 | 506.427 | 419.99 | 173.516 | 143.633 | 140.027 | 91.916 |
| Net Income Ratio
| 0.001 | -0.014 | 0.021 | 0.069 | 0.04 | 0.021 | 0.03 | 0.038 | 0.086 | 0.043 | 0.058 | 0.092 | 0.093 | 0.182 | 0.178 | 0.134 | 0.129 | 0.155 | 0.135 |
| EPS
| 0.011 | -0.13 | 0.22 | 0.84 | 0.4 | 0.25 | 0.34 | 0.34 | 0.2 | 0.064 | 0.15 | 0.17 | 0.19 | 0.25 | 0.24 | 0.11 | 0.095 | 0.1 | 0.069 |
| EPS Diluted
| 0.011 | -0.13 | 0.21 | 0.83 | 0.35 | 0.25 | 0.34 | 0.34 | 0.2 | 0.064 | 0.13 | 0.17 | 0.19 | 0.25 | 0.24 | 0.11 | 0.095 | 0.1 | 0.069 |
| EBITDA
| 2,053.518 | 1,605.593 | 2,358.391 | 4,083.129 | 2,166.108 | 1,535.595 | 1,618.05 | 1,535.342 | 1,009.738 | 598.877 | 748.383 | 657.638 | 537.064 | 707.398 | 574.829 | 310.929 | 239.015 | 180.627 | 142.535 |
| EBITDA Ratio
| 0.081 | 0.06 | 0.079 | 0.117 | 0.088 | 0.051 | 0.058 | 0.069 | 0.172 | 0.14 | 0.144 | 0.174 | 0.157 | 0.254 | 0.244 | 0.24 | 0.214 | 0.2 | 0.21 |